false
Q2
--12-31
0001069394
A0
0001069394
2024-01-01
2024-06-30
0001069394
2024-08-14
0001069394
2024-06-30
0001069394
2023-12-31
0001069394
2024-04-01
2024-06-30
0001069394
2023-04-01
2023-06-30
0001069394
2023-01-01
2023-06-30
0001069394
2022-12-31
0001069394
2023-06-30
0001069394
us-gaap:CommonStockMember
2023-12-31
0001069394
FSI:CapitalInExcessOfParValueMember
2023-12-31
0001069394
us-gaap:RetainedEarningsMember
2023-12-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0001069394
us-gaap:ParentMember
2023-12-31
0001069394
us-gaap:NoncontrollingInterestMember
2023-12-31
0001069394
us-gaap:CommonStockMember
2024-03-31
0001069394
FSI:CapitalInExcessOfParValueMember
2024-03-31
0001069394
us-gaap:RetainedEarningsMember
2024-03-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
0001069394
us-gaap:ParentMember
2024-03-31
0001069394
us-gaap:NoncontrollingInterestMember
2024-03-31
0001069394
2024-03-31
0001069394
us-gaap:CommonStockMember
2022-12-31
0001069394
FSI:CapitalInExcessOfParValueMember
2022-12-31
0001069394
us-gaap:RetainedEarningsMember
2022-12-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2022-12-31
0001069394
us-gaap:ParentMember
2022-12-31
0001069394
us-gaap:NoncontrollingInterestMember
2022-12-31
0001069394
us-gaap:CommonStockMember
2023-03-31
0001069394
FSI:CapitalInExcessOfParValueMember
2023-03-31
0001069394
us-gaap:RetainedEarningsMember
2023-03-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-03-31
0001069394
us-gaap:ParentMember
2023-03-31
0001069394
us-gaap:NoncontrollingInterestMember
2023-03-31
0001069394
2023-03-31
0001069394
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0001069394
FSI:CapitalInExcessOfParValueMember
2024-01-01
2024-03-31
0001069394
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-03-31
0001069394
us-gaap:ParentMember
2024-01-01
2024-03-31
0001069394
us-gaap:NoncontrollingInterestMember
2024-01-01
2024-03-31
0001069394
2024-01-01
2024-03-31
0001069394
us-gaap:CommonStockMember
2024-04-01
2024-06-30
0001069394
FSI:CapitalInExcessOfParValueMember
2024-04-01
2024-06-30
0001069394
us-gaap:RetainedEarningsMember
2024-04-01
2024-06-30
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-04-01
2024-06-30
0001069394
us-gaap:ParentMember
2024-04-01
2024-06-30
0001069394
us-gaap:NoncontrollingInterestMember
2024-04-01
2024-06-30
0001069394
us-gaap:CommonStockMember
2023-01-01
2023-03-31
0001069394
FSI:CapitalInExcessOfParValueMember
2023-01-01
2023-03-31
0001069394
us-gaap:RetainedEarningsMember
2023-01-01
2023-03-31
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-01-01
2023-03-31
0001069394
us-gaap:ParentMember
2023-01-01
2023-03-31
0001069394
us-gaap:NoncontrollingInterestMember
2023-01-01
2023-03-31
0001069394
2023-01-01
2023-03-31
0001069394
us-gaap:CommonStockMember
2023-04-01
2023-06-30
0001069394
FSI:CapitalInExcessOfParValueMember
2023-04-01
2023-06-30
0001069394
us-gaap:RetainedEarningsMember
2023-04-01
2023-06-30
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-04-01
2023-06-30
0001069394
us-gaap:ParentMember
2023-04-01
2023-06-30
0001069394
us-gaap:NoncontrollingInterestMember
2023-04-01
2023-06-30
0001069394
us-gaap:CommonStockMember
2024-06-30
0001069394
FSI:CapitalInExcessOfParValueMember
2024-06-30
0001069394
us-gaap:RetainedEarningsMember
2024-06-30
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-06-30
0001069394
us-gaap:ParentMember
2024-06-30
0001069394
us-gaap:NoncontrollingInterestMember
2024-06-30
0001069394
us-gaap:CommonStockMember
2023-06-30
0001069394
FSI:CapitalInExcessOfParValueMember
2023-06-30
0001069394
us-gaap:RetainedEarningsMember
2023-06-30
0001069394
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-06-30
0001069394
us-gaap:ParentMember
2023-06-30
0001069394
us-gaap:NoncontrollingInterestMember
2023-06-30
0001069394
FSI:MendotaLLCMember
2024-01-01
2024-06-30
0001069394
FSI:ENPInvestmentsLLCAndENPMendotaMember
2024-01-01
2024-06-30
0001069394
FSI:FirstTermMember
2024-06-30
0001069394
FSI:SecondTermMember
2024-06-30
0001069394
FSI:ThirdTermMember
2024-06-30
0001069394
FSI:FourthTermMember
2024-06-30
0001069394
us-gaap:ShippingAndHandlingMember
2024-01-01
2024-06-30
0001069394
us-gaap:ShippingAndHandlingMember
2023-01-01
2023-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:RevenueFromContractWithCustomerMember
2024-01-01
2024-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:RevenueFromContractWithCustomerMember
2023-01-01
2023-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:RevenueFromContractWithCustomerMember
2024-04-01
2024-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:RevenueFromContractWithCustomerMember
2023-04-01
2023-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:AccountsReceivableMember
2024-01-01
2024-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:AccountsReceivableMember
2023-01-01
2023-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:AccountsReceivableMember
2024-04-01
2024-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:AccountsReceivableMember
2023-04-01
2023-06-30
0001069394
FSI:ThreePrimaryCustomersMember
us-gaap:AccountsReceivableMember
2023-01-01
2023-12-31
0001069394
FSI:InvestmentMember
2024-01-01
2024-06-30
0001069394
us-gaap:MachineryAndEquipmentMember
2024-01-01
2024-06-30
0001069394
us-gaap:OfficeEquipmentMember
2024-01-01
2024-06-30
0001069394
us-gaap:BuildingAndBuildingImprovementsMember
2024-01-01
2024-06-30
0001069394
us-gaap:AutomobilesMember
2024-01-01
2024-06-30
0001069394
us-gaap:TechnologyEquipmentMember
2024-01-01
2024-06-30
0001069394
us-gaap:LeaseholdImprovementsMember
2024-01-01
2024-06-30
0001069394
us-gaap:CustomerRelationshipsMember
2024-01-01
2024-06-30
0001069394
2023-01-01
2023-12-31
0001069394
us-gaap:BuildingAndBuildingImprovementsMember
2024-06-30
0001069394
us-gaap:AutomobilesMember
2024-06-30
0001069394
us-gaap:OfficeEquipmentMember
2024-06-30
0001069394
us-gaap:MachineryAndEquipmentMember
2024-06-30
0001069394
us-gaap:LandMember
2024-06-30
0001069394
us-gaap:LeaseholdImprovementsMember
2024-06-30
0001069394
us-gaap:DevelopedTechnologyRightsMember
2024-06-30
0001069394
us-gaap:BuildingAndBuildingImprovementsMember
2023-12-31
0001069394
us-gaap:AutomobilesMember
2023-12-31
0001069394
us-gaap:OfficeEquipmentMember
2023-12-31
0001069394
us-gaap:MachineryAndEquipmentMember
2023-12-31
0001069394
us-gaap:LandMember
2023-12-31
0001069394
us-gaap:LeaseholdImprovementsMember
2023-12-31
0001069394
us-gaap:DevelopedTechnologyRightsMember
2023-12-31
0001069394
FSI:EnPInvestmentsCorporationLLCMember
2022-12-31
0001069394
FSI:EnPInvestmentsCorporationLLCMember
2023-01-01
2023-12-31
0001069394
FSI:EnPInvestmentsCorporationLLCMember
2023-12-31
0001069394
FSI:EnPInvestmentsCorporationLLCMember
2024-01-01
2024-06-30
0001069394
FSI:EnPInvestmentsCorporationLLCMember
2024-06-30
0001069394
us-gaap:FiniteLivedIntangibleAssetsMember
2024-06-30
0001069394
FSI:EnpPeruInvestmentsLlcMember
2016-12-31
0001069394
FSI:NanoChemMember
2016-12-31
0001069394
FSI:ENPInvestmentsLLCMember
2016-12-31
0001069394
FSI:NanoChemMember
2022-06-30
0001069394
FSI:ENPPeruMember
2022-06-01
2022-06-30
0001069394
FSI:ENPPeruMember
2022-06-30
0001069394
FSI:EnpnvestmentsLlcMember
2024-06-30
0001069394
FSI:EnpnvestmentsLlcMember
2024-06-30
0001069394
FSI:EnpnvestmentsLlcMember
2023-06-30
0001069394
FSI:AppliedHoldingCorpMember
2018-12-31
0001069394
2021-01-01
2021-12-31
0001069394
2023-10-31
0001069394
FSI:TrioOpportunityCorpMember
2018-12-31
0001069394
FSI:TrioOpportunityCorpMember
2023-04-30
0001069394
us-gaap:CommonClassBMember
FSI:TrioOpportunityCorpMember
2018-12-01
2018-12-31
0001069394
us-gaap:CommonClassBMember
FSI:TrioOpportunityCorpMember
2018-12-31
0001069394
FSI:FloridaBasedLLCMember
2019-01-31
0001069394
FSI:FloridaBasedLLCMember
2024-01-01
2024-06-30
0001069394
FSI:FloridaBasedLLCMember
2023-01-01
2023-06-30
0001069394
FSI:FloridaBasedLLCMember
2024-06-30
0001069394
FSI:FloridaBasedLLCMember
2023-12-31
0001069394
FSI:LygosIncMember
2020-12-01
2020-12-31
0001069394
FSI:LygosIncMember
2021-01-01
2021-12-31
0001069394
FSI:LygosIncMember
2021-12-31
0001069394
FSI:EnpPeruInvestmentsLlcMember
2024-01-01
2024-06-30
0001069394
FSI:EnpPeruInvestmentsLlcMember
2022-12-31
0001069394
FSI:EnpPeruInvestmentsLlcMember
2023-01-01
2023-12-31
0001069394
FSI:EnpPeruInvestmentsLlcMember
2023-12-31
0001069394
FSI:EnpPeruInvestmentsLlcMember
2024-06-30
0001069394
FSI:FloridaBasedLLCMember
2022-12-31
0001069394
FSI:FloridaBasedLLCMember
2023-01-01
2023-12-31
0001069394
FSI:StockYardAndBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2024-06-30
0001069394
FSI:StockYardAndBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2024-06-01
2024-06-30
0001069394
FSI:StockYardAndBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2023-12-31
0001069394
FSI:NewAgreementMember
FSI:NanoChemSolutionIncMember
FSI:StockYardAndBankMember
2024-06-30
0001069394
us-gaap:NoncontrollingInterestMember
FSI:StockYardAndBankMember
2024-06-30
0001069394
FSI:NewAgreementMember
FSI:NanoChemSolutionIncMember
FSI:StockYardAndBankMember
2023-12-31
0001069394
FSI:StockBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2023-06-30
0001069394
FSI:StockBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2023-06-01
2023-06-30
0001069394
FSI:StockBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2024-06-30
0001069394
FSI:StockBankMember
FSI:MidlandStatesBankMember
FSI:NewAgreementMember
2023-12-31
0001069394
FSI:NewAgreementMember
FSI:NanoChemSolutionIncMember
FSI:StockBankMember
us-gaap:RevolvingCreditFacilityMember
2024-06-30
0001069394
FSI:NewAgreementMember
FSI:NanoChemSolutionIncMember
FSI:StockBankMember
us-gaap:RevolvingCreditFacilityMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2020-01-31
0001069394
FSI:StockYardsBankTrustMember
FSI:EnpRealtyLLCMember
2020-01-01
2020-01-31
0001069394
FSI:StockYardsBankTrustMember
FSI:EnpRealtyLLCMember
2020-01-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2020-01-01
2020-01-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2024-01-01
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2023-01-01
2023-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPMendotaMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:NanoChemMember
2022-06-30
0001069394
FSI:StockYardsBankTrustMember
FSI:EnpRealtyLLCMember
2022-06-01
2022-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruInvestmentsMember
2022-06-30
0001069394
FSI:NanoChemMember
FSI:TermLoanMember
FSI:MidlandBankMember
2024-01-01
2024-06-30
0001069394
FSI:NanoChemMember
FSI:TermLoanMember
FSI:MidlandBankMember
2023-01-01
2023-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:NanoChemMember
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:NanoChemMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2020-01-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2020-01-01
2020-01-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2022-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2024-01-01
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2023-01-01
2023-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruOneMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:MidlandBankMember
FSI:ENPPeruInvestmentsMember
2022-06-01
2022-06-30
0001069394
FSI:ENPPeruInvestmentsMember
FSI:TermLoanMember
FSI:MidlandBankMember
2024-01-01
2024-06-30
0001069394
FSI:ENPPeruInvestmentsMember
FSI:TermLoanMember
FSI:MidlandBankMember
2023-01-01
2023-06-30
0001069394
FSI:ENPPeruInvestmentsMember
FSI:TermLoanMember
FSI:MidlandBankMember
2024-06-30
0001069394
FSI:ENPPeruInvestmentsMember
FSI:TermLoanMember
FSI:MidlandBankMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:NanoChemMember
2022-12-31
0001069394
FSI:TermLoanMember
FSI:NanoChemMember
2024-01-01
2024-06-30
0001069394
FSI:TermLoanMember
FSI:NanoChemMember
2023-01-01
2023-06-30
0001069394
FSI:TermLoanMember
FSI:NanoChemMember
2024-06-30
0001069394
FSI:TermLoanMember
FSI:NanoChemMember
2023-12-31
0001069394
FSI:TermLoanMember
FSI:MendotaMember
2023-06-30
0001069394
FSI:MendotaMember
FSI:TermLoanMember
2024-01-01
2024-06-30
0001069394
FSI:MendotaMember
FSI:TermLoanMember
2023-01-01
2023-06-30
0001069394
FSI:TermLoanMember
FSI:MendotaMember
2024-06-30
0001069394
FSI:TermLoanMember
FSI:MendotaMember
2023-12-31
0001069394
FSI:StockYardsBankTrustMember
2024-06-30
0001069394
FSI:StockYardsBankTrustMember
2023-12-31
0001069394
FSI:StockYardsBankTrustOneMember
2024-06-30
0001069394
FSI:StockYardsBankTrustOneMember
2023-12-31
0001069394
FSI:StockYardsBankTrustTwoMember
2024-06-30
0001069394
FSI:StockYardsBankTrustTwoMember
2023-12-31
0001069394
FSI:StockYardsBankTrustThreeMember
2024-06-30
0001069394
FSI:StockYardsBankTrustThreeMember
2023-12-31
0001069394
FSI:StockYardsBankTrustFourMember
2024-06-30
0001069394
FSI:StockYardsBankTrustFourMember
2023-12-31
0001069394
FSI:StockYardsBankTrustFiveMember
2024-06-30
0001069394
FSI:StockYardsBankTrustFiveMember
2023-12-31
0001069394
FSI:ConsultantsMember
2024-01-01
2024-06-30
0001069394
FSI:ConsultantsMember
2023-01-01
2023-06-30
0001069394
FSI:EmployeesMember
2024-01-01
2024-06-30
0001069394
FSI:EmployeesMember
2023-01-01
2023-06-30
0001069394
us-gaap:CanadaRevenueAgencyMember
2024-06-30
0001069394
us-gaap:CanadaRevenueAgencyMember
2023-06-30
0001069394
us-gaap:CanadaRevenueAgencyMember
2024-01-01
2024-06-30
0001069394
us-gaap:CanadaRevenueAgencyMember
2023-01-01
2023-06-30
0001069394
srt:MinimumMember
2022-12-31
0001069394
srt:MaximumMember
2022-12-31
0001069394
srt:MinimumMember
2023-01-01
2023-12-31
0001069394
srt:MaximumMember
2023-01-01
2023-12-31
0001069394
srt:MinimumMember
2023-12-31
0001069394
srt:MaximumMember
2023-12-31
0001069394
srt:MinimumMember
2024-01-01
2024-06-30
0001069394
srt:MaximumMember
2024-01-01
2024-06-30
0001069394
srt:MinimumMember
2024-06-30
0001069394
srt:MaximumMember
2024-06-30
0001069394
us-gaap:EmployeeStockOptionMember
2024-01-01
2024-06-30
0001069394
us-gaap:EmployeeStockOptionMember
2023-01-01
2023-06-30
0001069394
FSI:ENPInvestmentsLLCMember
2024-01-01
2024-06-30
0001069394
FSI:ENPInvestmentsLLCMember
2024-06-30
0001069394
FSI:ENPInvestmentsLLCMember
2023-01-01
2023-06-30
0001069394
FSI:ENPInvestmentsLLCMember
2023-12-31
0001069394
FSI:MendotaLLCMember
2024-06-30
0001069394
FSI:ENPInvestmentsLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2022-12-31
0001069394
FSI:ENPInvestmentsLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2023-01-01
2023-12-31
0001069394
FSI:ENPInvestmentsLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2023-12-31
0001069394
FSI:ENPInvestmentsLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2024-01-01
2024-06-30
0001069394
FSI:ENPInvestmentsLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2024-06-30
0001069394
FSI:MendotaLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2022-12-31
0001069394
FSI:MendotaLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2023-01-01
2023-12-31
0001069394
FSI:MendotaLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2023-12-31
0001069394
FSI:MendotaLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2024-01-01
2024-06-30
0001069394
FSI:MendotaLLCMember
FSI:OwnershipInterestPurchaseAgreementMember
2024-06-30
0001069394
us-gaap:AccountsReceivableMember
FSI:ThreeCustomersMember
2024-06-30
0001069394
FSI:ThreeCustomersMember
us-gaap:AccountsReceivableMember
2024-01-01
2024-06-30
0001069394
us-gaap:AccountsReceivableMember
FSI:ThreeCustomersMember
2023-06-30
0001069394
FSI:ThreeCustomersMember
us-gaap:AccountsReceivableMember
2023-01-01
2023-06-30
0001069394
FSI:EWCPMember
FSI:SegmentMember
2024-04-01
2024-06-30
0001069394
FSI:TPAMember
FSI:SegmentMember
2024-04-01
2024-06-30
0001069394
FSI:SegmentMember
2024-04-01
2024-06-30
0001069394
FSI:EWCPMember
FSI:SegmentMember
2023-04-01
2023-06-30
0001069394
FSI:TPAMember
FSI:SegmentMember
2023-04-01
2023-06-30
0001069394
FSI:SegmentMember
2023-04-01
2023-06-30
0001069394
FSI:EWCPMember
FSI:SegmentMember
2024-01-01
2024-06-30
0001069394
FSI:TPAMember
FSI:SegmentMember
2024-01-01
2024-06-30
0001069394
FSI:SegmentMember
2024-01-01
2024-06-30
0001069394
FSI:EWCPMember
FSI:SegmentMember
2023-01-01
2023-06-30
0001069394
FSI:TPAMember
FSI:SegmentMember
2023-01-01
2023-06-30
0001069394
FSI:SegmentMember
2023-01-01
2023-06-30
0001069394
country:CA
2024-01-01
2024-06-30
0001069394
country:CA
2023-01-01
2023-06-30
0001069394
FSI:UnitedStatesandAbroadMember
2024-01-01
2024-06-30
0001069394
FSI:UnitedStatesandAbroadMember
2023-01-01
2023-06-30
0001069394
country:CA
2024-06-30
0001069394
country:CA
2023-12-31
0001069394
country:US
2024-06-30
0001069394
country:US
2023-12-31
0001069394
us-gaap:SubsequentEventMember
FSI:EmployeesMember
2024-07-01
2024-07-31
0001069394
us-gaap:SubsequentEventMember
2024-08-09
2024-08-09
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
FSI:Segments
xbrli:pure
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
10-Q
☒ |
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the quarterly period ended June 30, 2024
OR
☐ |
TRANSITION
REPORT PURSUANT TO 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For
the transition period from ________ to ________
Commission
File Number: 001-31540
FLEXIBLE
SOLUTIONS INTERNATIONAL INC.
(Exact
Name of registrant as Specified in Its Charter)
|
|
71-1630889 |
(State
or other jurisdiction of |
|
(Employer |
incorporation
or organization) |
|
Identification
No.) |
6001
54 Ave. |
|
|
Taber,
Alberta, Canada |
|
T1G
1X4 |
(Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
telephone number: (403) 223-2995
N/A
(Former
name, former address and former fiscal year, if changed since last report)
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock |
|
FSI |
|
NYSE
American |
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒
Indicate
by check mark whether the registrant (1) has filed all reports to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934
during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant
to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and
post such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”,
“smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer ☐ |
Accelerated
filer ☐ |
|
|
Non-accelerated
filer ☒ |
Smaller
reporting company ☒ |
|
|
Emerging
growth company ☐ |
|
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): ☐ Yes ☒ No
Class
of Stock |
|
No.
Shares Outstanding |
|
Date |
Common |
|
12,450,532 |
|
August
14, 2024 |
FORM
10-Q
Index
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995.
All statements other than statements of historical fact are “forward-looking statements” for the purposes of the federal
and state securities laws, including, but not limited to: any projections of earnings, revenue or other financial items; any statements
of the plans, strategies and objectives of management for future operations; any statements concerning proposed new services or developments;
any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying
any of the foregoing.
Forward-looking
statements may include the words “may,” “could,” “will,” “estimate,” “intend,”
“continue,” “believe,” “expect” or “anticipate” or other similar words. These forward-looking
statements present our estimates and assumptions only as of the date of this report. Except for our ongoing obligation to disclose material
information as required by the federal securities laws, we do not intend, and undertake no obligation, to update any forward-looking
statement.
Although
we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially
from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as
well as any forward-looking statements, are subject to change and inherent risks and uncertainties. The factors impacting these risks
and uncertainties include but are not limited to:
|
● |
Increased
competitive pressures from existing competitors and new entrants; |
|
|
|
|
● |
Increases
in interest rates or our cost of borrowing or a default under any material debt agreement; |
|
|
|
|
● |
Deterioration
in general or regional economic conditions; |
|
|
|
|
● |
Adverse
state or federal legislation or regulation that increases the costs of compliance, or adverse findings by a regulator with respect
to existing operations; |
|
|
|
|
● |
Loss
of customers or sales weakness; |
|
|
|
|
● |
Inability
to achieve future sales levels or other operating results; |
|
|
|
|
● |
The
unavailability of funds for capital expenditures; |
|
|
|
|
● |
Operational
inefficiencies in distribution or other systems; and |
|
|
|
|
● |
New
tariffs relating to raw materials imported from China. |
For
a detailed description of these and other factors that could cause actual results to differ materially from those expressed in any forward-looking
statement, please see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023.
PART
I FINANCIAL INFORMATION
Item
1. Financial Statements.
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM CONSOLIDATED BALANCE SHEETS
(U.S.
Dollars)
|
|
June
30, 2024 |
|
|
December
31, 2023 |
|
|
|
(Unaudited) |
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Current |
|
|
|
|
|
|
|
|
Cash |
|
$ |
6,843,825 |
|
|
$ |
5,017,583 |
|
Term
deposits (Note 2) |
|
|
2,365,613 |
|
|
|
2,690,241 |
|
Accounts
receivable, net (Note 4) |
|
|
8,792,696 |
|
|
|
9,843,056 |
|
Inventories
(Note 5) |
|
|
10,333,958 |
|
|
|
11,134,889 |
|
Prepaid
expenses and deposits |
|
|
586,473 |
|
|
|
1,540,923 |
|
Total
current assets |
|
|
28,922,565 |
|
|
|
30,226,692 |
|
Property,
equipment and leaseholds, net (Note 6) |
|
|
13,976,733 |
|
|
|
13,171,787 |
|
Right
of use assets (Note 3) |
|
|
- |
|
|
|
115,293 |
|
Intangible
assets (Note 7) |
|
|
2,200,000 |
|
|
|
2,280,000 |
|
Long
term deposits (Note 8) |
|
|
2,521,905 |
|
|
|
824,254 |
|
Investments
(Note 9) |
|
|
5,904,624 |
|
|
|
6,033,960 |
|
Goodwill
(Note 7) |
|
|
2,534,275 |
|
|
|
2,534,275 |
|
Deferred
tax asset (Note 2) |
|
|
284,794 |
|
|
|
284,794 |
|
Total
Assets |
|
$ |
56,344,896 |
|
|
$ |
55,471,055 |
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Current |
|
|
|
|
|
|
|
|
Accounts
payable |
|
$ |
1,488,836 |
|
|
$ |
1,984,592 |
|
Accrued
liabilities |
|
|
1,258,609 |
|
|
|
284,131 |
|
Deferred
revenue |
|
|
79,917 |
|
|
|
148,292 |
|
Income
taxes payable |
|
|
5,307,642 |
|
|
|
4,485,213 |
|
Short
term line of credit (Note 10) |
|
|
619,844 |
|
|
|
1,810,479 |
|
Current
portion of lease liability (Note 3) |
|
|
- |
|
|
|
59,520 |
|
Current
portion of long term debt (Note 11) |
|
|
2,163,602 |
|
|
|
1,281,632 |
|
Total
current liabilities |
|
|
10,918,450 |
|
|
|
10,053,859 |
|
Lease
liability (Note 3) |
|
|
- |
|
|
|
55,773 |
|
Deferred
income tax liability (Note 2) |
|
|
260,047 |
|
|
|
260,047 |
|
Long
term debt (Note 11) |
|
|
6,102,531 |
|
|
|
6,833,304 |
|
Total
Liabilities |
|
|
17,281,028 |
|
|
|
17,202,983 |
|
|
|
|
|
|
|
|
|
|
Stockholders’
Equity |
|
|
|
|
|
|
|
|
Capital
stock (Note 13) |
|
|
|
|
|
|
|
|
Authorized:
50,000,000 common shares with a par value of $0.001 each; 1,000,000 preferred shares with a par value of $0.01 each |
|
|
|
|
|
|
|
|
Issued
and outstanding: |
|
|
|
|
|
|
|
|
12,450,532
(December 31, 2023: 12,435,532) common shares |
|
|
12,451 |
|
|
|
12,436 |
|
Common
stock, value |
|
|
12,451 |
|
|
|
12,436 |
|
|
|
|
|
|
|
|
|
|
Capital
in excess of par value |
|
|
18,337,510 |
|
|
|
17,932,015 |
|
Other
comprehensive loss |
|
|
(732,805 |
) |
|
|
(795,146 |
) |
Accumulated
earnings |
|
|
18,545,020 |
|
|
|
18,053,051 |
|
Total
stockholders’ equity – controlling interest |
|
|
36,162,176 |
|
|
|
35,202,356 |
|
Non-controlling
interests (Note 14) |
|
|
2,901,692 |
|
|
|
3,065,716 |
|
Total
Stockholders’ Equity |
|
|
39,063,868 |
|
|
|
38,268,072 |
|
Total
Liabilities and Stockholders’ Equity |
|
$ |
56,344,896 |
|
|
$ |
55,471,055 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)
(U.S.
Dollars — Unaudited)
|
|
2024 |
|
|
2023 |
|
|
|
Three
Months Ended June 30, |
|
|
|
2024 |
|
|
2023 |
|
Sales |
|
$ |
10,528,739 |
|
|
$ |
10,331,291 |
|
Cost
of sales |
|
|
6,589,644 |
|
|
|
7,292,438 |
|
Gross
profit |
|
|
3,939,095 |
|
|
|
3,038,853 |
|
|
|
|
|
|
|
|
|
|
Operating
Expenses |
|
|
|
|
|
|
|
|
Wages |
|
|
594,384 |
|
|
|
787,621 |
|
Administrative
salaries and benefits |
|
|
289,777 |
|
|
|
394,305 |
|
Insurance |
|
|
229,198 |
|
|
|
228,445 |
|
Office
and miscellaneous |
|
|
197,707 |
|
|
|
74,944 |
|
Interest
expense |
|
|
157,131 |
|
|
|
115,498 |
|
Consulting |
|
|
142,395 |
|
|
|
69,253 |
|
Professional
fees |
|
|
122,470 |
|
|
|
79,532 |
|
Utilities |
|
|
76,256 |
|
|
|
5,487 |
|
Advertising
and promotion |
|
|
63,283 |
|
|
|
62,011 |
|
Research |
|
|
62,474 |
|
|
|
15,833 |
|
Travel |
|
|
61,179 |
|
|
|
64,612 |
|
Currency
exchange |
|
|
47,681 |
|
|
|
13,925 |
|
Investor
relations and transfer agent fee |
|
|
46,174 |
|
|
|
32,993 |
|
Telecommunications |
|
|
15,996 |
|
|
|
10,432 |
|
Lease
expense |
|
|
12,195 |
|
|
|
27,645 |
|
Shipping |
|
|
7,014 |
|
|
|
5,100 |
|
Commissions |
|
|
|
|
|
|
|
|
Total
operating expenses |
|
|
2,125,314 |
|
|
|
1,987,636 |
|
|
|
|
|
|
|
|
|
|
Operating
income |
|
|
1,813,781 |
|
|
|
1,051,217 |
|
|
|
|
|
|
|
|
|
|
Gain
on investment |
|
|
115,463 |
|
|
|
256,708 |
|
Loss
on lease termination |
|
|
|
|
|
|
|
|
Interest
income |
|
|
61,440 |
|
|
|
41,174 |
|
|
|
|
|
|
|
|
|
|
Income
taxes |
|
|
|
|
|
|
|
|
Income
tax expense |
|
|
(558,251 |
) |
|
|
(354,372 |
) |
Net
income for the period including non-controlling interests |
|
|
1,432,433 |
|
|
|
994,727 |
|
Less:
Net income attributable to non-controlling interests |
|
|
(142,637
|
) |
|
|
(184,862 |
) |
Net
income attributable to controlling interest |
|
$ |
1,289,796 |
|
|
$ |
809,865 |
|
Income
per share (basic) |
|
$ |
0.10 |
|
|
$ |
0.07 |
|
Income
per share (diluted) |
|
$ |
0.10 |
|
|
$ |
0.06 |
|
|
|
|
|
|
|
|
|
|
Weighted
average number of common shares (basic) |
|
|
12,450,532 |
|
|
|
12,435,532 |
|
Weighted
average number of common shares (diluted) |
|
|
12,480,712 |
|
|
|
12,519,930 |
|
Other
comprehensive income (loss): |
|
|
|
|
|
|
|
|
Net
income |
|
|
1,432,433 |
|
|
|
994,727 |
|
Unrealized
income (loss) on foreign currency translations |
|
|
35,118 |
|
|
|
226,645 |
|
Total
comprehensive income |
|
$ |
1,467,551 |
|
|
$ |
1,221,372 |
|
Comprehensive
income – non-controlling interest |
|
|
(142,637 |
) |
|
|
(184,862 |
) |
Comprehensive
income attributable to Flexible Solutions International Inc. |
|
$ |
1,324,914 |
|
|
$ |
1,036,510 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND
COMPREHENSIVE
INCOME
(U.S.
Dollars — Unaudited)
|
|
2024 |
|
|
2023 |
|
|
|
Six
Months Ended June 30, |
|
|
|
2024 |
|
|
2023 |
|
Sales |
|
$ |
19,753,611 |
|
|
$ |
20,178,808 |
|
Cost
of sales |
|
|
12,994,149 |
|
|
|
14,054,963 |
|
Gross
profit |
|
|
6,759,462 |
|
|
|
6,123,845 |
|
|
|
|
|
|
|
|
|
|
Operating
Expenses |
|
|
|
|
|
|
|
|
Wages |
|
|
1,245,542 |
|
|
|
1,459,313 |
|
Administrative
salaries and benefits |
|
|
707,636 |
|
|
|
787,319 |
|
Insurance |
|
|
473,458 |
|
|
|
429,975 |
|
Office
and miscellaneous |
|
|
355,330 |
|
|
|
173,790 |
|
Interest
expense |
|
|
332,397 |
|
|
|
250,368 |
|
Consulting |
|
|
242,316 |
|
|
|
132,230 |
|
Research |
|
|
189,128 |
|
|
|
37,335 |
|
Professional
fees |
|
|
183,465 |
|
|
|
142,299 |
|
Utilities |
|
|
149,932 |
|
|
|
12,974 |
|
Advertising
and promotion |
|
|
130,232 |
|
|
|
110,409 |
|
Travel |
|
|
127,440 |
|
|
|
126,264 |
|
Investor
relations and transfer agent fee |
|
|
85,478 |
|
|
|
122,885 |
|
Currency
exchange |
|
|
46,046 |
|
|
|
16,501 |
|
Lease
expense |
|
|
42,345 |
|
|
|
52,940 |
|
Telecommunications |
|
|
29,528 |
|
|
|
23,010 |
|
Shipping |
|
|
14,843 |
|
|
|
9,766 |
|
Commissions |
|
|
- |
|
|
|
2,985 |
|
Total
operating expenses |
|
|
4,355,116 |
|
|
|
3,890,363 |
|
|
|
|
|
|
|
|
|
|
Operating
income |
|
|
2,404,346 |
|
|
|
2,233,482 |
|
Gain
on investment |
|
|
298,438 |
|
|
|
326,703 |
|
Loss
on lease termination |
|
|
(41,350 |
) |
|
|
- |
|
Interest
income |
|
|
109,637 |
|
|
|
53,185 |
|
|
|
|
|
|
|
|
|
|
Income
taxes |
|
|
|
|
|
|
|
|
Income
tax expense |
|
|
(822,429 |
) |
|
|
(654,149 |
) |
Net
income for the period including non-controlling interests |
|
|
1,948,642 |
|
|
|
1,959,221 |
|
Less:
Net income attributable to non-controlling interests |
|
|
(201,620 |
) |
|
|
(264,987 |
) |
Net
income attributable to controlling interest |
|
$ |
1,747,022 |
|
|
$ |
1,694,234 |
|
Income
per share (basic and diluted) |
|
$ |
0.14 |
|
|
$ |
0.14 |
|
Weighted
average number of common shares (basic) |
|
|
12,450,118 |
|
|
|
12,434,230 |
|
Weighted
average number of common shares (diluted) |
|
|
12,450,118 |
|
|
|
12,498,945 |
|
Other
comprehensive income: |
|
|
|
|
|
|
|
|
Net
income |
|
$ |
1,948,642 |
|
|
$ |
1,959,221 |
|
Unrealized
gain (loss) on foreign currency translations |
|
|
62,341 |
|
|
|
59,406 |
|
Total
comprehensive income |
|
$ |
2,010,983 |
|
|
$ |
2,018,627 |
|
Comprehensive
income – non-controlling interest |
|
|
(201,620 |
) |
|
|
(264,987 |
) |
Comprehensive
income attributable to Flexible Solutions International Inc. |
|
$ |
1,809,363 |
|
|
$ |
1,753,640 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
(U.S.
Dollars — Unaudited)
|
|
2024 |
|
|
2023 |
|
|
|
Six
Months Ended June 30, |
|
|
|
2024 |
|
|
2023 |
|
|
|
|
|
|
|
|
Operating
activities |
|
|
|
|
|
|
|
|
Net
income for the period including non-controlling interest |
|
$ |
1,948,642 |
|
|
$ |
1,959,221 |
|
Adjustments
to reconcile net income to cash provided by operations: |
|
|
|
|
|
|
|
|
Stock
based compensation |
|
|
379,260 |
|
|
|
366,526 |
|
Depreciation
and amortization |
|
|
939,524 |
|
|
|
751,574 |
|
Lease
right of use amortization |
|
|
13,694 |
|
|
|
25,687 |
|
Lease
right of use financing |
|
|
1,186 |
|
|
|
3,353 |
|
Loss
on termination lease |
|
|
41,350 |
|
|
|
- |
|
Gain
on investment |
|
|
(298,438 |
) |
|
|
(326,703 |
) |
|
|
|
|
|
|
|
|
|
Changes
in non-cash working capital items: |
|
|
|
|
|
|
|
|
(Increase)
Decrease in accounts receivable |
|
|
1,050,360 |
|
|
|
2,014,807 |
|
(Increase)
Decrease in inventories |
|
|
800,931 |
|
|
|
3,646,494 |
|
(Increase)
Decrease in prepaid expenses |
|
|
954,450 |
|
|
|
(558,583 |
) |
Increase
(Decrease) in accounts payable and accrued liabilities |
|
|
478,723 |
|
|
|
(8,821 |
) |
Increase
(Decrease) in taxes payable |
|
|
822,429 |
|
|
|
405,577 |
|
Increase
(Decrease) deferred revenue |
|
|
(68,375 |
) |
|
|
(352,357 |
) |
|
|
|
|
|
|
|
|
|
Cash
provided by operating activities |
|
|
7,063,736 |
|
|
|
7,926,775 |
|
|
|
|
|
|
|
|
|
|
Investing
activities |
|
|
|
|
|
|
|
|
Long
term deposits |
|
|
(1,703,091 |
) |
|
|
(361,616 |
) |
Proceeds
of equity method investment distributions |
|
|
427,000 |
|
|
|
- |
|
Net
purchase of property, equipment and leaseholds |
|
|
(1,663,697 |
) |
|
|
(3,784,193 |
) |
Non-controlling
interest of 317 Mendota |
|
|
- |
|
|
|
200,000 |
|
Additional
investment in Trio |
|
|
- |
|
|
|
(470,000 |
) |
|
|
|
|
|
|
|
|
|
Cash
(used in) investing activities |
|
|
(2,939,788 |
) |
|
|
(4,415,809 |
) |
|
|
|
|
|
|
|
|
|
Financing
activities |
|
|
|
|
|
|
|
|
Repayment
of short term line of credit |
|
|
(1,190,635 |
) |
|
|
(2,818,591 |
) |
Repayment
of long term debt |
|
|
(373,615 |
) |
|
|
(361,265 |
) |
Proceeds
from loans |
|
|
524,812 |
|
|
|
2,248,292 |
|
Dividends
paid |
|
|
(1,255,053 |
) |
|
|
(626,777 |
) |
Lease
financing costs |
|
|
(50,790 |
) |
|
|
(29,040 |
) |
Proceeds
of issuance of common stock |
|
|
26,250 |
|
|
|
13,600 |
|
|
|
|
|
|
|
|
|
|
Cash
(used in) financing activities |
|
|
(2,684,675 |
) |
|
|
(1,961,477 |
) |
|
|
|
|
|
|
|
|
|
Effect
of exchange rate changes on cash |
|
|
62,341 |
|
|
|
59,406 |
|
|
|
|
|
|
|
|
|
|
Inflow
(outflow) of cash |
|
|
1,501,614 |
|
|
|
1,608,895 |
|
Cash
and term deposits, beginning |
|
|
7,707,824 |
|
|
|
6,815,099 |
|
|
|
|
|
|
|
|
|
|
Cash
and term deposits, ending |
|
$ |
9,209,438 |
|
|
$ |
8,423,994 |
|
|
|
|
|
|
|
|
|
|
Cash
and term deposits are comprised of: |
|
|
|
|
|
|
|
|
Cash |
|
$ |
6,843,825 |
|
|
$ |
7,413,753 |
|
Term
deposits |
|
|
2,365,613 |
|
|
|
1,010,241 |
|
Cash and cash equivalents, ending |
|
$
|
9,209,438 |
|
|
$
|
8,423,994 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM Consolidated Statements of Stockholders’ Equity
(U.S.
Dollars – Unaudited)
|
|
Shares |
|
|
Par
Value |
|
|
Capital
in
Excess
of
Par
Value |
|
|
Accumulated
Earnings |
|
|
Other
Comprehensive
Income
(Loss) |
|
|
Total |
|
|
Non-
Controlling
Interests |
|
|
Total
Stockholders’
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
December 31, 2023 |
|
|
12,435,532 |
|
|
$ |
12,436 |
|
|
$ |
17,932,015 |
|
|
$ |
18,053,051 |
|
|
$ |
(795,146 |
) |
|
$ |
35,202,356 |
|
|
$ |
3,065,716 |
|
|
$ |
38,268,072 |
|
Translation
adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
27,223 |
|
|
|
27,223 |
|
|
|
— |
|
|
|
27,223 |
|
Net
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
457,226 |
|
|
|
— |
|
|
|
457,226 |
|
|
|
58,983 |
|
|
|
516,209 |
|
Common
stock issued |
|
|
15,000 |
|
|
|
15 |
|
|
|
26,235 |
|
|
|
— |
|
|
|
— |
|
|
|
26,250 |
|
|
|
— |
|
|
|
26,250 |
|
Stock-based
compensation |
|
|
— |
|
|
|
— |
|
|
|
253,357 |
|
|
|
— |
|
|
|
— |
|
|
|
253,357 |
|
|
|
— |
|
|
|
253,357 |
|
Balance
March 31, 2024 |
|
|
12,450,532 |
|
|
$ |
12,451 |
|
|
$ |
18,211,607 |
|
|
$ |
18,510,277 |
|
|
$ |
(767,923 |
) |
|
$ |
35,966,412 |
|
|
$ |
3,124,699 |
|
|
$ |
39,091,111 |
|
Translation
adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
35,118 |
|
|
|
35,118 |
|
|
|
— |
|
|
|
35,118 |
|
Net
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,289,796 |
|
|
|
— |
|
|
|
1,289,796 |
|
|
|
142,637 |
|
|
|
1,432,433 |
|
Dividends
paid |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,255,053 |
) |
|
|
— |
|
|
|
(1,255,053 |
) |
|
|
— |
|
|
|
(1,255,053 |
) |
Distributions
to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(365,644 |
) |
|
|
(365,644 |
) |
Stock-based
compensation |
|
|
— |
|
|
|
— |
|
|
|
125,903 |
|
|
|
— |
|
|
|
— |
|
|
|
125,903 |
|
|
|
— |
|
|
|
125,903 |
|
Balance
June 30, 2024 |
|
|
12,450,532 |
|
|
$ |
12,451 |
|
|
$ |
18,337,510 |
|
|
$ |
18,545,020 |
|
|
$ |
(732,805 |
) |
|
$ |
36,162,176 |
|
|
$ |
2,901,692 |
|
|
$ |
39,063,868 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
FLEXIBLE
SOLUTIONS INTERNATIONAL, INC.
CONDENSED
INTERIM Consolidated Statements of Stockholders’ Equity
(U.S.
Dollars – Unaudited)
|
|
Shares |
|
|
Par
Value |
|
|
Capital
in
Excess
of
Par
Value |
|
|
Accumulated
Earnings |
|
|
Other
Comprehensive
Income
(Loss) |
|
|
Total |
|
|
Non-
Controlling
Interests |
|
|
Total
Stockholders’
Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
December 31, 2022 |
|
|
12,426,260 |
|
|
$ |
12,426 |
|
|
$ |
17,523,345 |
|
|
$ |
15,903,964 |
|
|
$ |
(805,799 |
) |
|
$ |
32,633,936 |
|
|
$ |
2,605,034 |
|
|
$ |
35,238,970 |
|
Translation
adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(167,239 |
) |
|
|
(167,239 |
) |
|
|
— |
|
|
|
(167,239 |
) |
Net
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
884,369 |
|
|
|
— |
|
|
|
884,369 |
|
|
|
80,125 |
|
|
|
964,494 |
|
Common
stock issued |
|
|
9,272 |
|
|
|
10 |
|
|
|
13,590 |
|
|
|
— |
|
|
|
— |
|
|
|
13,600 |
|
|
|
— |
|
|
|
13,600 |
|
Stock-based
compensation |
|
|
— |
|
|
|
— |
|
|
|
185,298 |
|
|
|
— |
|
|
|
— |
|
|
|
185,298 |
|
|
|
— |
|
|
|
185,298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance
March 31, 2023 |
|
|
12,435,532 |
|
|
$ |
12,436 |
|
|
$ |
17,722,233 |
|
|
$ |
16,788,333 |
|
|
$ |
(973,038 |
) |
|
$ |
33,549,964 |
|
|
$ |
2,685,159 |
|
|
$ |
36,235,123 |
|
Balance |
|
|
12,435,532 |
|
|
$ |
12,436 |
|
|
$ |
17,722,233 |
|
|
$ |
16,788,333 |
|
|
$ |
(973,038 |
) |
|
$ |
33,549,964 |
|
|
$ |
2,685,159 |
|
|
$ |
36,235,123 |
|
Translation
adjustment |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
226,645 |
|
|
|
226,645 |
|
|
|
— |
|
|
|
226,645 |
|
Net
income |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
809,865 |
|
|
|
— |
|
|
|
809,865 |
|
|
|
184,862 |
|
|
|
994,727 |
|
Dividends
paid |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(626,777 |
) |
|
|
— |
|
|
|
(626,777 |
) |
|
|
— |
|
|
|
(626,777 |
) |
Non-controlling
interest of 317 Mendota LLC |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
200,000 |
|
|
|
200,000 |
|
Distributions
to noncontrolling interests |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(387,696 |
) |
|
|
(387,696 |
) |
Stock-based
compensation |
|
|
— |
|
|
|
— |
|
|
|
181,228 |
|
|
|
— |
|
|
|
— |
|
|
|
181,228 |
|
|
|
— |
|
|
|
181,228 |
|
Balance
June 30, 2023 |
|
|
12,435,532 |
|
|
$ |
12,436 |
|
|
$ |
17,903,461 |
|
|
$ |
16,971,421 |
|
|
$ |
(746,393 |
) |
|
$ |
34,140,925 |
|
|
$ |
2,682,325 |
|
|
$ |
36,823,250 |
|
Balance |
|
|
12,435,532 |
|
|
$ |
12,436 |
|
|
$ |
17,903,461 |
|
|
$ |
16,971,421 |
|
|
$ |
(746,393 |
) |
|
$ |
34,140,925 |
|
|
$ |
2,682,325 |
|
|
$ |
36,823,250 |
|
—
See Notes to Unaudited Condensed Interim Consolidated Financial Statements —
NOTES
TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For
the Six Months Ended June 30, 2024
(U.S.
Dollars - Unaudited)
1.
BASIS OF PRESENTATION
These
interim condensed consolidated financial statements (“consolidated financial statements”) include the accounts of Flexible
Solutions International, Inc. (the “Company”), its wholly-owned subsidiaries Flexible Fermentation Ltd., NanoChem Solutions
Inc. (“NanoChem”), Flexible Solutions Ltd., Flexible Biomass LP, FS Biomass Inc., NCS Deferred Corp., Natural Chem SEZC Ltd.,
InnFlex Holdings Inc., ENP Peru Investments LLC (“ENP Peru”), its 80% controlling interest in 317 Mendota LLC (“317
Mendota”), and its 65% controlling interest in ENP Investments, LLC (“ENP Investments”) and ENP Mendota, LLC (“ENP
Mendota”). All inter-company balances and transactions have been eliminated upon consolidation. The Company was incorporated on
May 12, 1998 in the State of Nevada and in 2019 the Company redomiciled into Alberta, Canada.
The
Company and its subsidiaries develop, manufacture and market specialty chemicals which slow the evaporation of water. One product, HEATSAVR®,
is marketed for use in swimming pools and spas where its use, by slowing the evaporation of water, allows the water to retain a higher
temperature for a longer period of time and thereby reduces the energy required to maintain the desired temperature of the water in the
pool. Another product, WATERSAVR®, is marketed for water conservation in irrigation canals, aquaculture, and reservoirs where its
use slows water loss due to evaporation. In addition to the water conservation products, the Company also manufactures and markets water-soluble
chemicals utilizing thermal polyaspartate biopolymers (hereinafter referred to as “TPAs”), which are beta-proteins manufactured
from the common biological amino acid, L-aspartic. TPAs can be formulated to prevent corrosion and scaling in water piping within the
petroleum, chemical, utility and mining industries. TPAs are also used as proteins to enhance fertilizers in improving crop yields and
can be used as additives for household laundry detergents, consumer care products and pesticides. The TPA division also manufactures
two nitrogen conservation products for agriculture that slows nitrogen loss from fields.
2.
SIGNIFICANT ACCOUNTING POLICIES
These
consolidated financial statements have been prepared on a historical cost basis, except where otherwise noted, in accordance with accounting
principles generally accepted in the United States applicable to a going concern and reflect the policies outlined below.
In
the opinion of management, the accompanying unaudited condensed interim consolidated financial statements contain all adjustments (all
of which are of a normal recurring nature) and disclosures necessary for a fair presentation of the Company’s financial position
as of June 30, 2024 and the results of its operations for the three and six months then ended. The consolidated balance sheet as of December
31, 2023 is derived from the December 31, 2023 audited financial statements.
Certain information and footnote disclosures normally included in financial statements prepared in accordance with
U.S, GAAP have been condensed or omitted. These unaudited condensed interim consolidated financial statements should be read in conjunction
with the consolidated financial statements and notes thereto included in our Form 10-K/A for the year ended December 31, 2023. The results
of operations for the period ended June 30, 2024 are not necessarily indicative of the operating results that may be expected for the
full year.
(a)
Cash and Cash Equivalents.
The
Company considers all highly liquid investments purchased with an original or remaining maturity of less than three months at the date
of purchase to be cash equivalents. Cash and cash equivalents are maintained with several financial institutions. As of June 30, 2024
and December 31, 2023, the Company did not have any cash equivalents.
(b)
Term Deposits.
The
Company has four term deposits that are maintained by commercials banks. The first term deposit is for $303,954 and
matures in February 2025. This deposit pays 1.3%
interest and if withdrawn before maturity, a penalty may be applied. The second term deposit is for $731,767,
matures in November 2024 and pays interest at a rate of 3.00%.
If withdrawn before maturity, the greater of the loss of accrued interest or $150,
plus 1% of the principal shall be levied. The third term deposit is for $1,019,197 and
matures in November 2024. This deposit pays 3.85%
and if withdrawn before maturity, the greater of the loss of accrued interest or $150,
plus 1% of the principal shall be levied. The fourth term deposit is for $310,695,
matures in August 2024 and pays interest at a rate of 3.85%.
If withdrawn before maturity, a penalty may be applied.
(c)
Inventories and Cost of Sales.
The
Company has three major classes of inventory: completed goods, work in progress and raw materials and supplies. In all classes inventories
are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis or weighted average cost formula
to inventories in different subsidiaries. Cost of sales includes all expenditures incurred in bringing the goods to the point of sale.
Inventory costs and costs of sales include direct costs of the raw material, inbound freight charges, warehousing costs, handling costs
(receiving and purchasing) and utilities and overhead expenses related to the Company’s manufacturing and processing facilities.
Shipping and handling charges billed to customers are included in revenue (2024 - $288,826; 2023 - $286,290). Shipping and handling costs
incurred are included in cost of goods sold (2024 - $509,167; 2023 - $542,321).
(d)
Allowance for expected credit losses.
The
Company’s expected credit losses are determined through a review using historical credit loss experience; changes in asset specific
characteristics, current conditions, and reasonable and supportable future forecasts, among other specific account data, and is performed
at least quarterly. The Company develops and documents its methodology to determine its allowance for expected credit losses. Risk characteristics
used by the Company may include customer mix, knowledge of customers and general economic conditions of the various local economics,
among others. Specific account balances are written off when management determines the amounts to be uncollectible. Management has reviewed
the balance reserved through the allowance for expected losses and believes it is reasonable.
(e)
Property, Equipment, Leaseholds and Intangible Assets.
The
following assets are recorded at cost and depreciated using the methods and annual rates shown below:
SCHEDULE OF METHOD OF DEPRECIATION
|
|
|
Manufacturing
equipment |
|
20%
Declining balance |
Office
equipment |
|
20%
Declining balance |
Building
and improvements |
|
10%
Declining balance |
Automobiles |
|
Straight-line
over 5 years |
Technology |
|
Straight-line
over 10 years |
Leasehold
improvements |
|
Straight-line
over lease term |
Customer
relationships |
|
Straight-line
over 15 years |
|
|
|
(f)
Impairment of Long-Lived Assets.
In
accordance with FASB Codification Topic 360, Property, Plant and Equipment (ASC 360), the Company reviews long-lived assets, including,
but not limited to, property, equipment and leaseholds, patents and other assets, for impairment annually or whenever events or changes
in circumstances indicate the carrying amounts of assets may not be recoverable. The carrying value of long-lived assets is assessed
for impairment by evaluating operating performance and future undiscounted cash flows of the underlying assets. If the expected future
cash flows of an asset is less than its carrying value, an impairment measurement is indicated. Impairment charges are recorded to the
extent that an asset’s carrying value exceeds its fair value. Accordingly, actual results could vary significantly from such estimates.
There were no impairment charges during the periods presented.
(g)
Foreign Currency.
The
functional currency of the Company is the U.S. dollar. The functional currency of three of the Company’s subsidiaries is the Canadian
dollar. The translation of the Canadian dollar to the reporting currency of the Company, the U.S. dollar, is performed for assets and
liabilities using exchange rates in effect at the balance sheet date. Revenue and expense transactions are translated using average exchange
rates prevailing during the period. Translation adjustments arising on conversion of the Company’s financial statements from the
subsidiary’s functional currency, Canadian dollars, into the reporting currency, U.S. dollars, are excluded from the determination
of income (loss) and are disclosed as other comprehensive income in the consolidated statements of income and comprehensive income.
Foreign
exchange gains and losses relating to transactions not denominated in the applicable local currency are included in operating income
(loss) if realized during the year and in comprehensive income (loss) if they remain unrealized at the end of the year.
(h)
Revenue Recognition.
The
Company generates revenue primarily from energy and water conservation products and biodegradable polymers, as further discussed in Note
15.
The
Company follows a five-step model for revenue recognition. The five steps are: (1) identification of the contract(s) with the customer,
(2) identification of the performance obligation(s) in the contract(s), (3) determination of the transaction price, (4) allocation of
the transaction price to the performance obligation, and (5) recognition of revenue when (or as) the performance obligation is satisfied.
The Company has fulfilled its performance obligations when control transfers to the customer, which is generally at the time the product
is shipped since risk of loss is transferred to the purchaser upon delivery to the carrier. For shipments which are free-on-board shipping
point, the Company has elected to account for shipping and handling activities as a fulfillment cost rather than as an additional promised
service and performance obligation.
Since
the Company’s inception, product returns have been insignificant; therefore, no provision has been established for estimated product
returns.
Deferred
revenues consist of products sold to distributors with payment terms greater than the Company’s customary business terms due to
lack of credit history or operating in a new market in which the Company has no prior experience. The Company defers the recognition
of revenue until the criteria for revenue recognition has been met and payments become due or cash is received from these distributors.
(i)
Stock Issued in Exchange for Services.
The
Company’s common stock issued in exchange for services is valued at estimated fair market value based upon trading prices of the
Company’s common stock on the dates of the stock transactions. The corresponding expense of the services rendered is recognized
over the period that the services are performed.
(j)
Stock-based Compensation.
The
Company recognizes compensation expense for all share-based payments in accordance with FASB Codification Topic 718, Compensation —
Stock Compensation (ASC 718). Under the fair value recognition provisions of ASC 718, the Company recognizes share-based compensation
expense, net of an estimated forfeiture rate, over the requisite service period of the award.
The
fair value at grant date of stock options is estimated using the Black-Scholes option-pricing model. Compensation expense is recognized
on a straight-line basis over the stock option vesting period based on the estimated number of stock options that are expected to vest.
Shares are issued from treasury upon exercise of stock options.
(k)
Other Comprehensive Income.
Other
comprehensive income refers to revenues, expenses, gains and losses that under generally accepted accounting principles are included
in comprehensive income, but are excluded from net income as these amounts are recorded directly as an adjustment to stockholders’
equity. The Company’s other comprehensive income is comprised only of unrealized foreign exchange gains and losses related to the
translation of subsidiaries’ functional currency into the reporting currency.
(l)
Income Per Share.
Basic
earnings per share is computed by dividing income available to common stockholders by the weighted average number of common shares outstanding
in the period. Diluted earnings per share are calculated giving effect to the potential dilution of the exercise of options and warrants.
Common equivalent shares, composed of incremental common shares issuable upon the exercise of stock options and warrants are included
in diluted net income per share to the extent that these shares are dilutive. Common equivalent shares that have an anti-dilutive effect
on net income per share have been excluded from the calculation of diluted weighted average shares outstanding for the three and six
months ended June 30, 2024 and 2023.
(m)
Use of Estimates.
The
preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated
financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from
those estimates and would impact the results of operations and cash flows.
Estimates
and underlying assumptions are reviewed at each period end. Revisions to accounting estimates are recognized in the period in which the
estimates are revised and in any future periods affected.
Significant
areas requiring the use of management estimates include assumptions and estimates relating to the valuation of goodwill and intangible
assets, valuation of assets acquired at fair value, asset impairment analysis, share-based payments, valuation allowances for deferred
income tax assets, determination of useful lives of property, equipment and leaseholds and intangible assets, recoverability of accounts
receivable, recoverability of investments, discount rates for right of use assets and the costing and recoverable value of inventory.
(n)
Fair Value of Financial Instruments.
Fair
value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal
or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date.
Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.
The standard describes a fair value hierarchy based on three levels of inputs described below, of which the first two are considered
observable and the last unobservable, that may be used to measure fair value.
|
● |
Level
1 – Quoted prices in active markets for identical assets or liabilities. |
|
● |
Level
2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets
or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable
market data for substantially the full term of the assets or liabilities. |
|
● |
Level
3 — Unobservable inputs that are supported by little or no market activity which is significant to the fair value of the assets
or liabilities. |
The
fair values of cash, term deposits, accounts receivable, accounts payable, accrued liabilities and the short term line of credit for
all periods presented approximate their respective carrying amounts due to the short term nature of these financial instruments.
The
fair value of the long term debt and lease liabilities for all periods presented approximate their respective carrying amounts due to
these financial instruments being at market rates.
(o)
Contingencies.
Certain
conditions may exist as of the date the consolidated financial statements are issued which may result in a loss to the Company but which
will only be resolved when one or more future events occur or fail to occur. The Company’s management and its legal counsel assess
such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related
to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s
legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount
of relief sought or expected to be sought therein.
If
the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability
can be estimated, the estimated liability would be accrued in the Company’s consolidated financial statements. If the assessment
indicates that a potential material loss contingency is not probable, but is reasonably possible, or is probable but cannot be estimated,
then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would
be disclosed.
Loss
contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed.
Legal fees associated with loss contingencies are expensed as incurred. The Company is not aware of any contingencies at the date of
these consolidated financial statements.
(p)
Income Taxes.
Income
taxes are computed by multiplying the Company’s taxable net income by the Company’s effective tax rates. Deferred income
tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial
statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss carry-forwards, if any.
Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which
those temporary differences are expected to be recovered or settled. The effect on deferred income tax assets and liabilities of a change
in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is provided to reduce the
carrying amount of deferred income tax assets if it is considered more likely than not that some portion, or all, of the deferred income
tax assets will not be realized.
In
accordance with FASB Codification Topic 740, Income taxes (ASC 740) under the liability method, it is the Company’s policy to provide
for uncertain tax positions and the related interest and penalties based upon management’s assessment of whether a tax benefit
is more likely than not to be sustained upon examination by tax authorities. At June 30, 2024, the Company believes it has appropriately
accounted for any unrecognized tax benefits.
To
the extent the Company prevails in matters for which a liability for an unrecognized benefit is established or is required to pay amounts
in excess of the liability, the Company’s effective tax rate in a given financial statement period may be affected. Interest and
penalties associated with the Company’s tax positions are recorded as interest expense in the consolidated statements of income
and comprehensive income.
(q)
Risk Management.
The
Company’s credit risk is primarily attributable to its accounts receivable. The amounts presented in the accompanying consolidated
balance sheets are net of allowances for doubtful accounts, estimated by the Company’s management based on prior experience and
the current economic environment. The Company is exposed to credit-related losses in the event of non-payment by customers. Credit exposure
is minimized by dealing with only credit worthy counterparties. Revenue for the Company’s three primary customers totaled $9,843,563
(50%)
for the six months ended June 30, 2024 (2023 - $9,276,058
or 46%)
and $5,520,361
(52%)
for the three months ended June 30, 2024 (2023 - $5,172,025
or 50%).
Accounts receivable for the Company’s three primary customers for the six months ended June 30, 2024 totaled $4,443,400
or 49%
(2023 - $4,172,657
or 56%).
Accounts receivable for the Company’s three primary customers for the three months ended June 30, 2024 totaled $4,333,665
or 49%
(2023 - $4,172,657
or 56%;
December 31, 2023 - $6,561,164
or 67%).
The
credit risk on cash is limited because the Company limits its exposure to credit loss by placing its cash with major financial institutions.
The Company maintains cash balances at financial institutions which at times exceed federally insured amounts. The Company has not experienced
any losses in such accounts.
The
Company is exposed to foreign risk to the extent that market value rate fluctuations materially differ for financial assets and liabilities
denominated in foreign currencies.
In
order to manage its exposure to foreign exchange risks, the Company closely monitors the fluctuations in the foreign currency exchange
rates and the impact on the value of cash, accounts receivable, and accounts payable and accrued liabilities. The Company has not hedged
its exposure to currency fluctuations.
The
Company is exposed to interest rate risk to the extent that the fair value or future cash flows for financial liabilities will fluctuate
as a result of changes in market interest rates. The Company is exposed to interest rate risk on its long-term debt subject to fixed
long-term interest rates.
In
order to manage its exposure to interest rate risk, the Company closely monitors fluctuations in market interest risks and will refinance
its long-term debt where possible to obtain more favourable rates.
(r)
Equity Method Investment.
The
Company accounts for investments using the equity method of accounting if the investment provides the Company the ability to exercise
significant influence, but not control, over the investee. Significant influence is generally deemed to exist if the Company’s
ownership interest in the voting stock of the investee ranges between 20% and 50%, although other factors, such as representation on
the investee’s board of directors, are considered in determining whether the equity method of accounting is appropriate. Under
the equity method of accounting, the investment is initially recorded at cost in the consolidated balance sheets under other assets and
adjusted for dividends received and the Company’s share of the investee’s earnings or losses together with other-than-temporary
impairments which are recorded through other income (loss), net in the consolidated statements of operations and comprehensive income
(loss).
(s)
Goodwill and Intangible Assets.
Goodwill
represents the excess of the purchase price of an acquired entity over the amounts assigned to the assets acquired and liabilities assumed.
Goodwill is not amortized, but is reviewed for impairment annually or more frequently if certain impairment conditions arise. The Company
performs an annual goodwill impairment review in the fourth quarter of each year at the reporting unit level. The evaluation begins with
a qualitative assessment of the factors that could impact the significant inputs used to estimate fair value. If after performing the
qualitative assessment, it is determined that it is more likely than not that the fair value of a reporting unit is greater than its
carrying amount, including goodwill, then no further analysis is necessary. However, if the results of the qualitative test are unclear,
the Company performs a quantitative test, which involves comparing the fair value of a reporting unit with its carrying amount, including
goodwill. The Company uses an income-based valuation method, determining the present value of future cash flows, to estimate the fair
value of a reporting unit. If the fair value of a reporting unit exceeds its carrying amount, goodwill of the reporting unit is considered
not impaired, and no further analysis is necessary. If the fair value of the reporting unit is less than its carrying amount, goodwill
impairment would be recognized equal to the amount of the carrying value in excess of the reporting unit’s fair value, limited
to the total amount of goodwill allocated to the reporting unit.
Intangible
assets primarily include trademarks and trade secrets with indefinite lives and customer-relationships with finite lives. Intangible
assets with indefinite lives are not amortized but are tested for impairment on an annual basis, or more frequently if indicators of
impairment are present. Indefinite lived intangible assets are assessed using either a qualitative or a quantitative approach. The qualitative
assessment evaluates factors including macro-economic conditions, industry and company-specific factors, legal and regulatory environments,
and historical company performance in assessing fair value. If it is determined that it is more likely than not that the fair value of
the intangible asset is less than its carrying value, a quantitative test is then performed. Otherwise, no further testing is required.
When using a quantitative approach, the Company compares the fair value of the intangible asset to its carrying amount. If the estimated
fair value of the intangible asset is less than the carrying amount of the intangible asset, impairment is indicated, requiring recognition
of an impairment charge for the differential.
In
accordance with FASB Codification Topic 350, Intangibles – Goodwill and Other, (ASC 350), qualitative assessments of goodwill and
indefinite-lived intangible assets were performed at December 31, 2023. Based on the results of the assessment, it was determined that
it is more likely than not the reporting unit, customer lists and trademarks had a fair value in excess of their carrying amounts. Accordingly,
no further impairment testing was completed and no impairment charges related to goodwill or indefinite-lived intangibles were recognized
during the three or six months ended June 30, 2024.
Finite-lived
intangible assets are amortized on a straight-line basis over their estimated useful lives. The Company reviews for impairment indicators
of finite-lived intangibles and other long-lived assets as described in the “Impairment of Long Lived Assets” significant
accounting policy.
(t)
Recent Accounting Pronouncements.
The
Company has implemented all applicable new accounting pronouncements that are in effect. Those pronouncements did not have any material
impact on the consolidated financial statements unless otherwise disclosed, and the Company does not believe that there are any other
new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
3.
LEASES
Leases
are evaluated and classified as either operating or finance leases by the lessee and as either operating, sales-type or direct financing
leases by the lessor. For leases with terms greater than 12 months, the Company records the related right-of-use (“ROU”)
asset and lease obligation at the present value of lease payments over the term. Leases may include fixed rental escalation clauses,
renewal options and / or termination options that are factored into the determination of lease payments when appropriate. The Company’s
operating leases are included in ROU assets, lease liabilities-current portion and lease liability-long term portion in the accompanying
consolidated balance sheets. ROU assets represent the Company’s right to use an underlying asset for the lease term, and lease
liabilities represent the obligation to make lease payments arising from the lease. The Company’s leases do not usually provide
a readily determinable implicit rate; therefore, an estimate of the Company’s incremental borrowing rate is used to discount the
lease payments based on information available at the lease commencement date. The discount rate used was 5.5%.
In
March 2024, the Company consolidated NanoChem operations into the Peril, IL locations and terminated the lease in Naperville, IL. The
Company had to pay a penalty of $35,910 and forfeited the $5,440 security deposit to terminate the lease early and incurred a loss of
$41,350 on early termination of the lease. The table below summarizes the right-of-use asset and lease liability for the periods ended
June 30, 2024 and December 31, 2023.
SUMMARY OF RIGHT-OF-USE ASSET AND LEASE LIABILITY
Right
of Use Assets |
|
|
|
|
Balance
at December 31, 2022 |
|
$ |
167,222 |
|
Depreciation |
|
|
(51,929 |
) |
Balance
at December 31, 2023 |
|
$ |
115,293 |
|
Depreciation |
|
|
(13,694 |
) |
Early
termination of lease |
|
|
(101,599 |
) |
Balance
at June 30, 2024 |
|
$ |
- |
|
|
|
|
|
|
Lease
Liability |
|
|
|
|
Balance
at December 31, 2022 |
|
$ |
167,222 |
|
Lease
interest expense |
|
|
6,151 |
|
Payments |
|
|
(58,080 |
) |
Balance
at December 31, 2023 |
|
$ |
115,293 |
|
Lease
interest expense |
|
|
1,186 |
|
Payments |
|
|
(14,880 |
) |
Early
termination of lease |
|
|
(101,599 |
) |
Balance
at June 30, 2024 |
|
$ |
- |
|
4.
ACCOUNTS RECEIVABLE
SCHEDULE OF ACCOUNTS RECEIVABLE
|
|
June
30, 2024 |
|
|
December
31, 2023 |
|
|
|
|
|
|
|
|
Accounts
receivable |
|
$ |
9,081,600 |
|
|
$ |
|